Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 2012. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a minor acquisition of Ordinary Shares by a connected person:
- Connected Person: Mrs. K Thomson (connected to Director Mr. P C Thomson).
- Transaction Date: September 11, 2012.
- Price: 1,429.89 pence per Ordinary Share.
- Acquisition Details:
- 3 Ordinary Shares acquired under the personal contribution element of the ShareReward Plan.
- 3 Ordinary Shares acquired under the matching element (Company contribution) of the Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly limited to the notification of the share transaction described above.
Investor Verification Points
- Verify the total number of shares held by Mrs. K Thomson post-transaction to assess total exposure.
- Confirm the terms of the ShareReward Plan to understand the vesting schedule or restrictions on the acquired shares.
- Check for any other concurrent filings by Mr. P C Thomson or other directors for a broader view of insider activity.